Daewoong Strikes New Deal For Botox Rival

After a past deal with Evolus to sell the product in the U.S. and Europe, Daewoong is searching for other markets in Asia and Latin America for its Botox competitor, and has just linked up with Turkey's Seltek.

More from South Korea

More from Focus On Asia